Doxorubicin

nucleolin ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33860446 Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin. 2022 Mar 2
2 35425440 DNA aptamer-based dual-responsive nanoplatform for targeted MRI and combination therapy for cancer. 2022 Jan 28 2
3 35565346 Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. 2022 Apr 29 2
4 33833512 Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. 2021 1
5 34207464 The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. 2021 Jun 18 1
6 34542145 Microenvironment-responsive DNA-conjugated albumin nanocarriers for targeted therapy. 2021 Oct 20 1
7 34591471 PEGylated Nanoscale Metal-Organic Frameworks for Targeted Cancer Imaging and Drug Delivery. 2021 Oct 20 1
8 32223128 Electrochemiluminescence Biosensor for Nucleolin Imaging in a Single Tumor Cell Combined with Synergetic Therapy of Tumor. 2020 Apr 24 2
9 32658190 Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery. 2020 Jun 23 1
10 30320343 Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells. 2019 Jan 1
11 31127617 Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells. 2019 Dec 7
12 31202169 A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer. 2019 Sep 1
13 31418358 [Effect of Inhibiting NCL Expression on Drug-Resistance of Chronic Myeloid Leukemia Cell Line K562 and Its Resistant Cells]. 2019 Aug 4
14 31546295 Combination of Doxorubicin with Gemcitabine-Incorporated G-Quadruplex Aptamer Showed Synergistic and Selective Anticancer Effect in Breast Cancer Cells. 2019 Nov 28 2
15 28690315 Targeting nucleolin for better survival in diffuse large B-cell lymphoma. 2018 Mar 2
16 29902537 Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity. 2018 Sep 1 1
17 30007600 Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma. 2018 Oct 1 1
18 30172067 A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications. 2018 Oct 1 2
19 30245388 Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency. 2018 Dec 1
20 30362711 Endogenous Stimuli-Responsive Nucleus-Targeted Nanocarrier for Intracellular mRNA Imaging and Drug Delivery. 2018 Nov 21 1
21 28264987 Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. 2017 Apr 1
22 26142627 Aptamer-functionalized hydrogel as effective anti-cancer drugs delivery agents. 2015 Oct 1 1
23 25305563 Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination. 2014 Dec 28 1
24 21805188 Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer. 2012 May 1
25 20510077 [Effect of down-regulation of nucleolin on adriamycin-induced apoptosis and inhibition of proliferation in breast cancer cells]. 2010 Apr 1